News

Published on 27 Feb 2024 on GuruFocus.com via Yahoo Finance

Causeway International Value Sheds iShares MSCI EAFE ETF in Q4


Article preview image

Insight into Causeway International Value (Trades, Portfolio)'s Latest Portfolio Adjustments

Warning! GuruFocus has detected 8 Warning Signs with LSE:RR..

Causeway International Value (Trades, Portfolio), known for its value-driven investment approach, has revealed its N-PORT filing for the fourth quarter of 2023. The fund, which launched on October 26, 2001, targets long-term capital and income growth through investments in developed non-U.S. markets, with a focus on dividend-paying or share-repurchasing companies. With a strategy that includes a three-stage investment processscreening and initial analysis, fundamental research, and portfolio constructionthe fund emphasizes a bottom-up approach to stock selection, favoring mid- to large-cap stocks that complement a U.S. portfolio.

PAR.ALO price evolution
SIX.ROG price evolution
SIX.ZURN price evolution
NYSE.EFA price evolution
LSE.RR price evolution
LSE.RKT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Roche Holding AG (RHHVF): Morgan Stanley is Bullish on This European AI Stock...

We recently compiled a list of the 15 Best European AI Stocks According to Morgan Stanley. In thi...

Insider Monkey · via Yahoo Finance 21 Aug 2024

Exploring Swiss Dividend Stocks In May 2024

Amidst a backdrop of fluctuating market conditions, the Swiss market demonstrated resilience, clo...

Simply Wall St. via Yahoo Finance 31 May 2024

Three Leading Swiss Dividend Stocks With Yields Up To 6.1%

Swiss stocks experienced a downturn on Tuesday, influenced by global economic concerns including ...

Simply Wall St. via Yahoo Finance 30 May 2024

Goldman Sachs downgrades Roche stock, cites pessimistic margin forecasts By Investing.com

On Thursday, Goldman Sachs initiated coverage on Roche Holding AG (OTC:RHHVF) (ROG:SW) (OTC: RHHB...

Investing.com 30 May 2024

Goldman Sachs Says Buy European Pharma Stocks Touting Innovation

(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have ...

Bloomberg via Yahoo Finance 30 May 2024

Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag

Roche Holding AG RHHBY announced that the FDA has accepted its new drug application (NDA) seeking...

Zacks via Yahoo Finance 29 May 2024

Where Will Novo Nordisk Be in 10 Years?

Novo Nordisk (NYSE: NVO) has been a fantastic, market-beating stock to own for the past decade. I...

Motley Fool via Yahoo Finance 25 May 2024

Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study

Roche Holding AG RHHBY announced that the late-stage study evaluating its marketed drug, Columvi ...

Zacks via Yahoo Finance 15 Apr 2024

Roche, Eli Lilly gain FDA breakthrough device tag for Alzheimer's blood test (OTCQX:RHHBY)

Roche and Eli Lilly's Elecsys pTau217 assay received FDA Breakthrough Device Designation for earl...

Seeking Alpha 11 Apr 2024

Roche test wins CE Mark to identify metastatic breast cancer patients (OTCQX:RHHBY)

Roche obtained CE Mark for its HER2 test, making it the first companion diagnostic for HER2-low...

Seeking Alpha 10 Apr 2024